In 2024, MolPort SIA had revenue of 4.4 million EUR and loss of 258.4 thousand EUR. The company has 24 employees. Beneficial owners: Jānis Ošlejs.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 4,4m € -21.6% | 5,6m € -23.1% | 7,3m € -6.8% |
Profit | -258,4k € -53.0% | -168,9k € -202.3% | 165,1k € +248.3% |
Assets | 2,3m € -6.1% | 2,5m € -17.0% | 3m € -24.6% |
Liabilities | 995k € +12.0% | 888,8k € -31.3% | 1,3m € -46.9% |
Equity | 1,3m € -16.2% | 1,6m € -6.2% | 1,7m € +10.7% |
Employees | 26 -3.7% | 27 +0.0% | 27 -28.9% |
Overall rating | C+64/100 |
Financial health | 40/100 |
Credit history | 80/100 |
Legal history | 100/100 |
Business activity | 35/100 |
| Overall risk | Medium |
No risk flags | |
No tax debts | |
Negative profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| Board chairman | Independently |
| Name | Changed |
|---|---|
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
| Sabiedrība ar ierobežotu atbildību "Chemospace" | 7 February 2007 |
MolPort SIA is located at Rīga, Lāčplēša iela 41, LV-1011.
In 2024, MolPort SIA had revenue of 4 379 035 EUR and loss of 258 389 EUR. Compared to previous year, revenue decreased by 21.6%. View full financial report →
In 2024, MolPort SIA had an average of 24 employees. View tax history →
The beneficial owners of MolPort SIA are Jānis Ošlejs. View ownership details →
Yes, MolPort SIA is registered as an active VAT payer with VAT number LV40003881547.
In 2024, the average gross salary at MolPort SIA was approximately 2578,96 € per month (net ~ 1849,63 €). This is an approximate calculation. View salary details →
MolPort SIA was founded on December 13, 2006. The company has been operating for 20 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 20 years | 5 - 9 | 91% | |
Net revenue | 4 379 035,00 € | 2 - 6 | 95% | |
Profit | -258 389,00 € | 64 - 66 | 2% | |
Equity | 1 338 031,00 € | 4 - 8 | 88% | |
Assets | 2 333 050,00 € | 3 - 7 | 94% | |
Fixed assets | 16 355,00 € | - | 75% | |
Liquidity | 1.08 | - | 40% | |
Profitability | -5.9% | - | 10% | |
Registered capital | 1 065 640,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Birth date | Shares | Ownership rights | |
|---|---|---|---|---|
| KS AIF Imprimatur Capital Technology Venture Fund | - | 324 411 | 30.44% | |
| Sabiedrība ar ierobežotu atbildību "PrimeThermo" | - | 414 170 | 38.87% | |
| Kristaps Bošs | 9000 | 0.84% | ||
| Normunds Kinne | 17 000 | 1.60% | ||
| Ieva Klūga | 14 000 | 1.31% | ||
| Komandītsabiedrība "FlyCap Investment Fund I AIF" | - | 78 740 | 7.39% | |
| KS AIF Imprimatur Capital Seed Fund | - | 64 503 | 6.05% | |
| Andrii Lozoniuk | 20 455 | 1.92% | ||
| Oxford Drug Design Limited | - | 62 890 | 5.90% | |
| Imants Zudāns | 60 471 | 5.67% | ||
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Jānis Ošlejs | LV |